Impact of Molecular Syndromic Diagnosis of Severe Pneumonia in the Management of Critically Ill Patients

Impact of Molecular Syndromic Diagnosis of Severe Pneumonia in the Management of Critically Ill Patients

ABSTRACT The impact of syndromic molecular diagnosis in the management of nosocomial infections caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) pathogens has been incompletely characterized. We evaluated the performance of a molecular syndromic platform (BioFire FilmArray-Pn...

Full description

Bibliographic Details
Main Authors: Dimitra Stafylaki, Sofia Maraki, Katerina Vaporidi, Dimitrios Georgopoulos, Dimitrios P. Kontoyiannis, Diamantis P. Kofteridis, Georgios Chamilos
Format: Article
Language:English
Published: American Society for Microbiology 2022-10-01
Series:Microbiology Spectrum
Subjects:
ICU
severe CAP
syndromic testing
VAP
multidrug resistance
pneumonia
Online Access:https://journals.asm.org/doi/10.1128/spectrum.01616-22

Internet

https://journals.asm.org/doi/10.1128/spectrum.01616-22

Similar Items